BRISBANE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical…
Poulos, former Head of Business Development at AbbVie, brings significant operational experience to support the Company's growth strategy in women’s…
Chicago to host 2025 Grand Rounds ConferenceCHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The Chicago Biomedical Consortium (“CBC”), a Midwest center…
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery…
100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a…
MONTREAL and CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on…
No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11,…
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For…
Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential Commercialization SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE…
Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ETWALTHAM, Mass., Feb. 11, 2025 (GLOBE…